{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:46:05Z","timestamp":1760060765422,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Cholesterolosis is a relatively common, yet often incidental, histopathological finding in cholecystectomy specimens, frequently associated with chronic cholecystitis. Although its clinical significance remains unclear, possible associations with glycemic regulation have been proposed. This study aimed to examine the relationship between cholesterolosis, glycemic parameters, and inflammatory markers in patients with chronic cholecystitis. Methods: We retrospectively analyzed gallbladder specimens from patients who underwent cholecystectomy for chronic cholecystitis between 2014 and 2023. Histopathology assessed cholesterolosis presence, distribution, and inflammatory features. Patients were grouped according to diabetes status (diabetic vs. non-diabetic) as well as the presence or absence of cholesterolosis. Demographic data, gallstone status, one-year mean fasting glucose, HbA1c levels, and hematological\/inflammatory indices were compared between groups. Results: Among diabetic patients, those with cholesterolosis had significantly lower fasting glucose than those without cholesterolosis (129.04 \u00b1 28.02 vs. 158.41 \u00b1 54.23 mg\/dL, p &lt; 0.05). The presence of cholesterolosis was not significantly associated with diabetes status (p &gt; 0.05). Inflammatory indices, including neutrophil count, did not differ significantly between groups (p &gt; 0.05), although fasting glucose correlated positively with neutrophil count (r = 0.167, p &lt; 0.05). Gallstones were less frequent in cholesterolosis cases compared with non-cholesterolosis cases (59.4% vs. 75%, p &lt; 0.05), suggesting a distinct pathophysiology. Conclusions: This is the first study to assess one-year glycemic profiles in diabetic and non-diabetic patients with and without cholesterolosis. The findings suggest that cholesterolosis may occur independently of poor glycemic control and systemic inflammation, supporting the concept of a distinct underlying mechanism.<\/jats:p>","DOI":"10.3390\/jcm14186500","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:33:02Z","timestamp":1758007982000},"page":"6500","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological Evaluation of Cholesterolosis in Cholecystitis: Histopathological Patterns and Metabolic Correlates"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-627X","authenticated-orcid":false,"given":"Damla G\u00fcl","family":"F\u0131nd\u0131k","sequence":"first","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Bilecik \u015eeyh Edebali University, 11230 Bilecik, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2152-0542","authenticated-orcid":false,"given":"Erhan","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Bilecik \u015eeyh Edebali University, 11230 Bilecik, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-9171","authenticated-orcid":false,"given":"\u00d6zlem","family":"T\u00fcrelik","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Bilecik \u015eeyh Edebali University, 11230 Bilecik, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"ref_1","unstructured":"Hamasha, R., and Gonzalez, R. (2023, June 04). Cholesterolosis. Available online: https:\/\/www.pathologyoutlines.com\/topic\/gallbladdercholesterolosis.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jss.2015.08.037","article-title":"Implications of gallbladder cholesterolosis and cholesterol polyps?","volume":"200","author":"Dairi","year":"2016","journal-title":"J. Surg. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/PAS.0000000000001405","article-title":"Non-neoplastic polyps of the gallbladder: A clinicopathologic analysis of 447 cases","volume":"44","author":"Taskin","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/njcp.njcp_353_18","article-title":"Is there any relationship between clinical parameters and histopathologic features of gallbladder specimens obtained from living liver donors?","volume":"22","author":"Akbulut","year":"2019","journal-title":"Niger. J. Clin. Pr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11010-014-2225-x","article-title":"Pioglitazone reduces lipid droplets in cholesterolosis of the gallbladder by increasing ABCA1 and NCEH1 expression","volume":"399","author":"Wang","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s00125-014-3347-0","article-title":"Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss","volume":"57","author":"Dharuri","year":"2014","journal-title":"Diabetologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00261-022-03680-5","article-title":"Spectrum of imaging findings in hyperplastic cholecystosis and potential mimics","volume":"48","author":"Malik","year":"2023","journal-title":"Abdom. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.31393\/morphology-journal-2021-27(1)-08","article-title":"Gallbladder cholesterolosis in patients with metabolic syndrome and chronic pancreatitis","volume":"27","author":"Petrushenko","year":"2021","journal-title":"Rep. Morphol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Leng, S., Zhao, A., Li, Q., Pei, L., Zheng, W., Liang, R., and Yan, H. (2018). Metabolic status and lifestyle factors associated with gallbladder polyps: A covariance structure analysis. BMC Gastroenterol., 18.","DOI":"10.1186\/s12876-018-0882-z"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1097\/CM9.0000000000001065","article-title":"Clinical factors associated with the number of gallbladder polyps","volume":"133","author":"Lu","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_11","first-page":"789","article-title":"The effect of high serum lipid level on benign gallbladder diseases","volume":"11","author":"Uyan","year":"2022","journal-title":"Medicine"},{"key":"ref_12","first-page":"902","article-title":"The Impact of Body Mass Index as a Predictive Factor of Steatocholecystitis","volume":"61","author":"Yoon","year":"2014","journal-title":"Hepato-Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10620-008-0578-2","article-title":"Steatocholecystitis and fatty gallbladder disease","volume":"54","author":"Tsai","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3892\/etm.2021.10190","article-title":"Clinical and therapeutic features of acute cholecystitis in diabetic patients","volume":"22","author":"Serban","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4274\/eajem.galenos.2024.23281","article-title":"Relationship Between Diabetes and Acalculose Cholestitis in the Elderly","volume":"23","author":"Dolanbay","year":"2024","journal-title":"Eurasian J. Emerg. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ijsu.2014.08.402","article-title":"Cholesterolosis in routine histopathological examination after cholecystectomy: What should a surgeon behold in the reports?","volume":"12","author":"Yaylak","year":"2014","journal-title":"Int. J. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Xue, Y., Zhang, D., Liu, Y., Xu, Z., Gao, J., Li, W., and Li, X. (2021). Effect of vitamin D supplementation on glycemic control in prediabetes: A meta-analysis. Nutrients, 13.","DOI":"10.3390\/nu13124464"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13098-022-00924-8","article-title":"Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: A meta-analysis of randomized controlled trials","volume":"14","author":"Yu","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/jamainternmed.2022.3810","article-title":"Acute cholecystitis associated with the use of glucagon-like peptide-1 receptor agonists reported to the US Food and Drug Administration","volume":"182","author":"Woronow","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.2337\/dc22-1095","article-title":"Dipeptidyl peptidase 4 inhibitors and gallbladder or biliary diseases: Data from the US Food and Drug Administration Adverse Event Reporting System","volume":"46","author":"He","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13098-024-01526-2","article-title":"The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study","volume":"16","author":"Gameil","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"He, L., Li, J., Cheng, X., Luo, L., and Huang, Y. (2025). Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: Pharmacovigilance analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1509561"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Terasaki, M., Yashima, H., Mori, Y., Saito, T., Matsui, T., Hiromura, M., Kushima, H., Osaka, N., Ohara, M., and Fukui, T. (2020). A dipeptidyl peptidase-4 inhibitor inhibits foam cell formation of macrophages in type 1 diabetes via suppression of CD36 and ACAT-1 expression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134811"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12944-019-1159-4","article-title":"Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet","volume":"18","author":"Han","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_25","first-page":"140","article-title":"Morphological spectrum of gallstone disease in 1100 cholecystectomies in North India","volume":"67","author":"Mohan","year":"2005","journal-title":"Indian J. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2478\/v10034-007-0007-4","article-title":"Gallstone disease and cholesterolosis in monozygotic twin sisters","volume":"10","author":"Sharashkina","year":"2007","journal-title":"Balk. J. Med. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ejlt.201100294","article-title":"Cholesteryl esters and ACAT","volume":"114","author":"Pramfalk","year":"2012","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5009\/gnl15600","article-title":"MUC expression in gallbladder epithelial tissues in cholesterol-associated gallbladder disease","volume":"10","author":"Yoo","year":"2016","journal-title":"Gut Liver"},{"key":"ref_29","first-page":"6","article-title":"Histopathological spectrum of diseases in gallbladder","volume":"6","author":"Beena","year":"2017","journal-title":"Natl. J. Lab. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4103\/0973-1482.187301","article-title":"Therapeutics. Importance of routine histopathological examination of a gallbladder surgical specimen: Unexpected gallbladder cancer","volume":"14","author":"Dincel","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"42557","DOI":"10.1074\/jbc.M202151200","article-title":"Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin","volume":"277","author":"Yeaman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kanter, J.E., Hsu, C.-C., and Bornfeldt, K.E. (2020). Monocytes and macrophages as protagonists in vascular complications of diabetes. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00010"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6500\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:01Z","timestamp":1760035561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":32,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14186500"],"URL":"https:\/\/doi.org\/10.3390\/jcm14186500","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}